Cardiovascular Care

(1018) Assessing Lipid Targets: A General Internal Medicine Patient Evaluation for Optimal Lipid Lowering Outcomes

(1019) Effect of a Community Pharmacy Cardiovascular Practice Transformation (CPT) Program on Blood Pressure

(1020) Effect of the FDA Statement on Low-dose Aspirin Recommendation for Primary Prevention of Cardiovascular Disease Among Older Adults with Diabetes: A Population-based Analysis of NHANES 2011-2018

(1021) Eligibility of Mineralocorticoid Receptor Antagonists for Hfref Patients in an Outpatient Family Care Practice Setting

(1022) Evaluation of Heart Failure with Reduced Ejection Fraction (HFrEF) Guideline Directed Medical Therapy Regimens​

(1023) Hypertension Action Planning Service

(1024) Implementation and Impact of Community-based Pharmacist Follow up for Patients Newly Initiated on Anti-hypertensive Medications

(1025) Incidence of Cerebrovascular and Bleeding Events in a Real-world Cohort of Patients with Mechanical Aortic On-x Valves Managed with Warfarin at INR Goals 1.5-2.0 and 2.0-3.0

(1026) Pharmacist-led Anti-hyperlipidemic Screening at an Outpatient Family Practice Clinic

(1030) The Use of INPEFA™ (Sotagliflozin) in the Reduction of Hospitalization for Heart Failure and Urgent Heart Failure Visit: A Scoping Review

(1031) What Predicts Longer Time to Clinical Recognition and Documentation of Hypertension for Patients with High Blood Pressure